The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Open accessAbstract
Single-cell expression profiles of melanoma: Tumors harbor multiple cell types that are thought to play a role in the development of resistance to drug treatments. Tirosh et al. used single-cell sequencing to investigate the distribution of these differing genetic profiles within melanomas. Many cells harbored heterogeneous genetic programs that reflected two different states of genetic expression, one of which was linked to resistance development. Following drug treatment, the resistance-linked expression state was found at a much higher level. Furthermore, the environment of the melanoma cells affected their gene expression programs. Science , this issue p. 189
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SALL4-regulated genes showed a significant enrichment and positive correlation with published invasiveness signatures40–42, while they significantly anti-correlated with their corresponding proliferation signatures40–42”
From Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 (2021) · cites this paper as [42]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“among the SALL4-HDAC2 targets upregulated upon SALL4 knockdown, we found integrins (ITGB1, ITGA6, ITGA4), N-cadherin (CDH2), TGFBR2, VEGFR-1, PDGFC, LOXL2, MAPK8, and many others which are associated with invasive melanoma phenotypes40–42”
From Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 (2021) · cites this paper as [42]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Consistent with previous reports in mice 43 , the proportions of HSCs expressing G2/M/S-phase genes were enhanced upon IFNa treatment ( Fig. 2h,i) .”
From Type 1 interferon perturbates clonal competition by reshaping human blood development (2026) · cites this paper as [43]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“As IFNa has been shown to induce HSC and progenitors into cell cycle entry 43 , we posited that differential induction of progenitor subtypes into proliferation may underlie the shifts in differentiation.”
From Type 1 interferon perturbates clonal competition by reshaping human blood development (2026) · cites this paper as [43]
Experimental — accuracy not yet measuredIn the citing paper
“Almost all previous work quantifying differences between single-cell datasets relies on discrete partitioning of the data before downstream analysis9–16.”
From Quantifying the effect of experimental perturbations at single-cell resolution (2021) · cites this paper as [11]
In the citing paper
“Cell cycle genes56 were excluded from this feature set and the dataset was subsetted to the resulting gene set.”
From Inferring and perturbing cell fate regulomes in human brain organoids (2023) · cites this paper as [56]
In the citing paper
“We used the union of the selected genes and TFs and further excluded cell-cycle-related genes56 from the set.”
From Inferring and perturbing cell fate regulomes in human brain organoids (2023) · cites this paper as [56]
In the citing paper
“Through deconvolution of complex samples30, such as tumor biopsies35, one may infer their cellular milieu, and characterize the rare5, functionally important1, and unknown36 cell types they contain.”
From Revealing the vectors of cellular identity with single-cell genomics (2016) · cites this paper as [35]
In the citing paper
“Several studies inferred the cell cycle phase of individual cells from single-cell RNA-seq data30,35,97,99, relying on transcriptional signatures of discrete phases from earlier bulk profiling experiments146.”
From Revealing the vectors of cellular identity with single-cell genomics (2016) · cites this paper as [35]
In the citing paper
“We performed latent variable regression to mitigate heterogeneity resulting from cell-cycle state10,11 (Extended Data Fig. 1), preventing subsequent analysis from being dominated by mitotic phase-specific gene expression”
From Developmental diversification of cortical inhibitory interneurons (2018) · cites this paper as [11]
In the citing paper
“In parallel, methods to measure the transcriptomes of single cells have been used to discover new cell types11 and new functional cell states12,13, and provide additional motivation for the development of tools to measure chromatin regulation at single-cell resolution14.”
From Droplet-based combinatorial indexing for massive-scale single-cell chromatin accessibility (2019) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
(2008) · Journal of Machine Learning Research · Cited by 33,051
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
(1996) · Cited by 20,179
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay‐Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,320
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,033
Single-cell analyses identify circulating anti-tumor CD8 T cells and markers for their enrichment
Pauken, K. E., Shahid, O., Lagattuta, K. A., Mahuron, K. M., Luber, J. M., Lowe, M. M., Huang, L., Delaney, C., Long, J. M., Fung, M. E., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20200920 · Cited by 116
Zheng, X., Song, J., Yu, C., Zhou, Z., Liu, X., Yu, J., Xu, G., Yang, J., He, X., Bai, X., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00881-8 · Cited by 116
A single-cell atlas of diffuse large B cell lymphoma
Ye, X., Wang, L., Nie, M., Wang, Y., Dong, S., Ren, W., Li, G., Li, Z., Wu, K., & Pan‐Hammarström, Q. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110713 · Cited by 116
Cell cycle gene regulation dynamics revealed by RNA velocity and deep-learning
Riba, A., Oravecz, A., Durik, M., Jiménez, S., Alunni, V., Cerciat, M., Jung, M., Keime, C., Keyes, W. M., & Molina, N. (2022) · Nature Communications · doi:10.1038/s41467-022-30545-8 · Cited by 116
Luo, Y., Xia, Y., Liu, D., Li, X., Li, H., Liu, J., Zhou, D., Dong, Y. J., Li, X., Qian, Y., et al. (2024) · Cell · doi:10.1016/j.cell.2024.06.013 · Cited by 120
Comparative analysis of sequencing technologies for single-cell transcriptomics
Natarajan, K. N., Miao, Z., Jiang, M., Huang, X., Zhou, H., Xie, J., Wang, C., Qin, S., Zhao, Z., Wu, L. L., et al. (2019) · Genome biology · doi:10.1186/s13059-019-1676-5 · Cited by 115
Ostrowski, S. M., & Fisher, D. E. (2020) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2020.08.010 · Cited by 115
Chen, K., Wang, Y., Hou, Y., Wang, Q., Long, D., Liu, X., Tian, X., & Yang, Y. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215834 · Cited by 115
Liu, L. A., Kim, S., Buckley, M. T., Reyes, J. M., Kang, J., Tian, L., Wang, M., Lieu, A. C., Mao, M., Rodríguez-Mateo, C., et al. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.03.016 · Cited by 115
Wang, H., Wang, T., Yan, S., Tang, J., Zhang, Y., Wang, L., Xu, H., & Tu, C. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02183-9 · Cited by 122
TREM2-independent microgliosis promotes tau-mediated neurodegeneration in the presence of ApoE4.
Gratuze, M., Schlachetzki, J. C. M., D’Oliveira Albanus, R., Jain, N., Novotny, B., Brase, L., Rodriguez, L., Mansel, C., Kipnis, M., O’Brien, S., et al. (2023) · Neuron · doi:10.1016/j.neuron.2022.10.022 · Cited by 115
Efficient Generation of Transcriptomic Profiles by Random Composite Measurements
Cleary, B., Cong, L., Cheung, A., Lander, E. S., & Regev, A. (2017) · Cell · doi:10.1016/j.cell.2017.10.023 · Cited by 114
Self-citationLau, X., Munusamy, P., Ng, M. J., & Sangrithi, M. N. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.07.018 · Cited by 114
Peng, C., Huggins, M. A., Wanhainen, K. M., Knutson, T. P., Lu, H., Georgiev, H., Mittelsteadt, K. L., Jarjour, N. N., Wang, H., Hogquist, K. A., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.11.017 · Cited by 114
Mechanisms of Drug Resistance in Melanoma
Winder, M. L., & Virós, A. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_17 · Cited by 112
Circulating Tumor Cells as a Tool for Assessing Tumor Heterogeneity
Tellez-Gabriel, M., Heymann, M., & Heymann, D. (2019) · Theranostics · doi:10.7150/thno.34337 · Cited by 112
Minn, K. T., Fu, Y. C., He, S., Dietmann, S., George, S. C., Anastasio, M. A., Morris, S. A., & Solnica‐Krezel, L. (2020) · eLife · doi:10.7554/elife.59445 · Cited by 112
Sun, T., Song, D., Li, W. V., & Li, J. J. (2021) · Genome biology · doi:10.1186/s13059-021-02367-2 · Cited by 115
Minoli, M., Cantore, T., Hanhart, D., Kiener, M., Fedrizzi, T., Manna, F. L., Karkampouna, S., Chouvardas, P., Genitsch, V., Rodríguez-Calero, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37696-2 · Cited by 112
Cancer heterogeneity is not compatible with one unique cancer cell metabolic map
Strickaert, A., Saiselet, M., Dom, G., Deken, X. D., Dumont, J. E., Féron, O., Sonveaux, P., & Maenhaut, C. (2016) · Oncogene · doi:10.1038/onc.2016.411 · Cited by 111
Kunz, M., Loeffler‐Wirth, H., Dannemann, M., Willscher, E., Doose, G., Kelso, J. F., Kottek, T., Nickel, B., Hopp, L., Landsberg, J., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0385-y · Cited by 111
Cell composition analysis of bulk genomics using single-cell data
Frishberg, A., Peshes‐Yaloz, N., Cohn, O., Rosentul, D. C., Steuerman, Y., Valadarsky, L., Yankovitz, G., Mandelboim, M., Iraqi, F. A., Amit, I., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0355-5 · Cited by 111
Gerosa, L., Chidley, C., Fröhlich, F., Sanchez, G., Lim, S. K., Muhlich, J. L., Chen, J.-Y., Vallabhaneni, S., Baker, G. J., Schapiro, D., et al. (2020) · Cell Systems · doi:10.1016/j.cels.2020.10.002 · Cited by 111
Self-citationYu, Z., Lv, Y., Su, C., Lu, W., Zhang, R., Li, J., Guo, B., Yan, H., Liu, D., Yang, Z., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-2224 · Cited by 116
Puram, S. V., Mints, M., Pal, A., Qi, Z., Reeb, A. N., Gelev, K. Z., Barrett, T. F., Gerndt, S. P., Liu, P., Parikh, A. S., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01357-3 · Cited by 111
Self-citationItaconate transporter SLC13A3 impairs tumor immunity via endowing ferroptosis resistance
Lin, H., Tison, K., Du, Y., Kirchhoff, P. D., Kim, C., Wang, W., Yang, H., Pitter, M. R., Yu, J., Liao, P., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.10.010 · Cited by 111
Studying hematopoiesis using single-cell technologies
Ye, F., Huang, W., & Guo, G. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0401-7 · Cited by 111
Kim, H., Park, S., Jeong, S., Lee, Y. J., Lee, H., Kim, C. G., Kim, K. H., Hong, S., Lee, J., Kim, S., et al. (2019) · Hepatology · doi:10.1002/hep.30881 · Cited by 110
FlsnRNA-seq: protoplasting-free full-length single-nucleus RNA profiling in plants
Long, Y., Liu, Z., Jia, J., Mo, W., Fang, L., Lu, D., Liu, B., Zhang, H., Chen, W., & Zhai, J. (2021) · Genome biology · doi:10.1186/s13059-021-02288-0 · Cited by 110
Self-citationDignum, T., Varnum‐Finney, B., Srivatsan, S. R., Dozono, S., Waltner, O. G., Heck, A. M., Ishida, T., Nourigat-Mckay, C., Jackson, D. L., Rafii, S., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109675 · Cited by 110
Alvisi, G., Termanini, A., Soldani, C., Portale, F., Carriero, R., Pilipow, K., Costa, G., Polidoro, M. A., Franceschini, B., Malenica, I., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.05.043 · Cited by 114
Focus on cutaneous and uveal melanoma specificitiesPreprint
Pandiani, C., Béranger, G. E., Leclerc, J., Ballotti, R., & Bertolotto, C. (2017) · Genes & Development · doi:10.1101/gad.296962.117 · Cited by 110
Droplet-based single cell RNAseq tools: a practical guide
Salomon, R., Kaczorowski, D., Valdes-Mora, F., Nordon, R. E., Neild, A., Farbehi, N., Bartonicek, N., & Gallego-Ortega, D. (2019) · Lab on a Chip · doi:10.1039/c8lc01239c · Cited by 109
FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease
García‐Recio, S., Thennavan, A., East, M. P., Parker, J. S., Cejalvo, J. M., Garay, J. P., Hollern, D. P., He, X., Mott, K. R., Galván, P., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci130323 · Cited by 109
Xiao, J., Yu, X., Meng, F., Zhang, Y., Zhou, W., Ren, Y., Li, J., Sun, Y., Sun, H., Chen, G., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06598-6 · Cited by 119
Gutierrez, C., Al’Khafaji, A. M., Brenner, E. A., Johnson, K. E., Gohil, S. H., Lin, Z., Knisbacher, B. A., Durrett, R., Li, S., Parvin, S., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00222-8 · Cited by 109
Li, J., Smalley, I., Chen, Z., Wu, J.-Y., Phadke, M. S., Teer, J. K., Nguyen, T., Karreth, F. A., Koomen, J. M., Sarnaik, A. A., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-3145 · Cited by 108
Wang, A. Z., Bowman-Kirigin, J. A., Desai, R. R., Kang, L., Patel, P. R., Patel, B., Khan, S. M., Bender, D. E., Marlin, M. C., Liu, J., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01051-9 · Cited by 111
Simonson, B., Chaffin, M. D., Hill, M. C., Atwa, O., Guedira, Y., Bhasin, H., Hall, A. W., Hayat, S., Baumgart, S. J., Bedi, K. C., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112086 · Cited by 108
Huang, X., Pang, M.-J., Li, J.-Y., Chen, H., Sun, J., Song, Y., Ni, H.-J., Ye, S.-Y., Bai, S., Li, T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36310-9 · Cited by 115
Bai, X., Fisher, D. E., & Flaherty, K. T. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0204-6 · Cited by 107
Self-citationThe Role of TAM Family Receptors in Immune Cell Function: Implications for Cancer Therapy
Paolino, M., & Penninger, J. M. (2016) · Cancers · doi:10.3390/cancers8100097 · Cited by 107
Inertial-ordering-assisted droplet microfluidics for high-throughput single-cell RNA-sequencing
Moon, H., Je, K., Min, J.-W., Park, D., Han, K., Shin, S., Park, W., Yoo, C. E., & Kim, S. (2018) · Lab on a Chip · doi:10.1039/c7lc01284e · Cited by 107
Tang, Y., Durand, S., Dalle, S., & Caramel, J. (2020) · Cancers · doi:10.3390/cancers12082154 · Cited by 106
Gan, Y., Huang, X., Zou, G., Zhou, S., & Guan, J. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac018 · Cited by 106
Raynaud, F., Mina, M., Tavernari, D., & Ciriello, G. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007669 · Cited by 106
Chang, W. H., & Lai, A. G. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0572-9 · Cited by 105
The ubiquitin ligase MDM2 sustains STAT5 stability to control T cell-mediated antitumor immunity
Zhou, J., Kryczek, I., Li, S., Xiong, L., Aguilar, A., Wei, S., Grove, S., Vatan, L., Yu, J., Yan, Y., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-00888-3 · Cited by 107
Chung, H. K., McDonald, B., & Kaech, S. M. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20201730 · Cited by 105
Single-Cell RNA Sequencing with Spatial Transcriptomics of Cancer Tissues
Ahmed, R., Zaman, T., Chowdhury, F., Mraiche, F., Tariq, M., Ahmad, I. S., & Hasan, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063042 · Cited by 105
Cherif, H., Mannarino, M., Pacis, A., Ragoussis, J., Rabau, O., Ouellet, J. A., & Haglund, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073993 · Cited by 105
Verma, S., Budhu, S., Serganova, I. S., Dong, L., Mangarin, L. M. B., Khan, J. F., Bah, M. A., Assouvie, A., Marouf, Y., Schulze, I., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci177606 · Cited by 105
Okoye, I., Houghton, M., Tyrrell, D. L., Barakat, K., & Elahi, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01215 · Cited by 105
CD8+ T-cell exhaustion in cancer: mechanisms and new area for cancer immunotherapy
He, Q., Xu, Y., Li, J., Huang, Z., Li, X., & Wang, X. (2018) · Briefings in Functional Genomics · doi:10.1093/bfgp/ely006 · Cited by 104
Dysfunction of Hair Follicle Mesenchymal Progenitors Contributes to Age-Associated Hair Loss
Shin, W., Rosin, N. L., Sparks, H. D., Sinha, S., Rahmani, W. M., Sharma, N. C., Workentine, M., Abbasi, S., Labit, E., Stratton, J. A., et al. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.03.019 · Cited by 105
Boroughs, A. C., Larson, R. C., Marjanovic, N. D., Gosik, K., Castaño, A. P., Porter, C. B. M., Lorrey, S., Ashenberg, O., Jerby‐Arnon, L., Hofree, M., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.07.023 · Cited by 104
Self-citationTumor-promoting macrophages prevail in malignant ascites of advanced gastric cancer
Eum, H. H., Kwon, M., Ryu, D., Jo, A., Chung, W., Kim, N., Hong, Y., Son, D., Kim, S. T., Lee, J., et al. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00538-y · Cited by 104
The cellular architecture of the antimicrobial response network in human leprosy granulomas
Ma, F., Hughes, T. K., Teles, R. M. B., Andrade, P. R., Silva, B. J. D. A., Plazyo, O., Tsoi, L. C., Do, T. H., Wadsworth, M. H., Oulee, A., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-00956-8 · Cited by 104
Self-citationZEB1 transcription factor promotes immune escape in melanoma
Plaschka, M., Benboubker, V., Grimont, M., Berthet, J., Tonon, L., Lopez, J., Bouar, M. L., Balme, B., Tondeur, G., de la Fouchardière, A., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003484 · Cited by 104
The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation
Maurus, K., Hufnagel, A., Geiger, F., Graf, S., Berking, C., Heinemann, A., Paschen, A., Kneitz, S., Stigloher, C., Geissinger, E., et al. (2017) · Oncogene · doi:10.1038/onc.2017.135 · Cited by 104
Buzdin, A. A., Sorokin, M., Garazha, A., Sekacheva, M. I., Kim, E. L., Zhukov, N. V., Wang, Y., Li, X., Kar, S., Hartmann, C. J., et al. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.06.003 · Cited by 103
Identification of two distinct pathways of human myelopoiesis
Drissen, R., Thongjuea, S., Theilgaard‐Mönch, K., & Nerlov, C. (2019) · Science Immunology · doi:10.1126/sciimmunol.aau7148 · Cited by 103
Isolating live cell clones from barcoded populations using CRISPRa-inducible reporters
Umkehrer, C., Holstein, F., Formenti, L., Jude, J., Froussios, K., Neumann, T., Cronin, S. M., Haas, L., Lipp, J., Burkard, T. R., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0614-0 · Cited by 103
Wang, S., Zhang, Q., Hui, H., Agrawal, K., Karris, M., & Rana, T. M. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1826361 · Cited by 103
Pandiani, C., Strub, T., Nottet, N., Chéli, Y., Gambi, G., Bille, K., Husser, C., Dalmasso, M., Béranger, G. E., Lassalle, S., et al. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-020-00730-7 · Cited by 103
Huuhtanen, J., Kasanen, H. H. E., Peltola, K. J., Lönnberg, T., Glumoff, V., Brück, O. E., Dufva, O., Peltonen, K., Vikkula, J., Jokinen, E., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci164809 · Cited by 103
Corre, S., Tardif, N., Mouchet, N., Leclair, H. M., Boussemart, L., Gautron, A., Bachelot, L., Perrot, A., Soshilov, A. A., Rogiers, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06951-2 · Cited by 102
Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancer
Ge, J. Y., Shu, S., Kwon, M., Jovanović, B., Murphy, K. C., Gulvady, A. C., Fassl, A., Trinh, A. C., Kuang, Y., Heavey, G. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16170-3 · Cited by 102
The Stress-Like Cancer Cell State Is a Consistent Component of Tumorigenesis
Baron, M., Tagore, M. M., Hunter, M. V., Kim, I. S., Moncada, R. M., Yan, Y., Campbell, N. R., White, R. M., & Yanai, I. (2020) · Cell Systems · doi:10.1016/j.cels.2020.08.018 · Cited by 104
Mapping the cardiac vascular niche in heart failure
Peisker, F., Halder, M., Nagai, J. S., Ziegler, S. M., Kaesler, N., Hoeft, K., Li, R., Bindels, E. M., Kuppe, C., Moellmann, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30682-0 · Cited by 103
Dou, S., Wang, Q., Zhang, B., Wei, C., Wang, H., Liu, T., Duan, H., Jiang, H., Liu, M., Qi, X., et al. (2022) · Cell Discovery · doi:10.1038/s41421-022-00397-z · Cited by 102
Shin, D., Lee, W., Lee, J. H., & Bang, D. (2019) · Science Advances · doi:10.1126/sciadv.aav2249 · Cited by 101
Myelin insulation as a risk factor for axonal degeneration in autoimmune demyelinating disease
Schäffner, E., Bosch-Queralt, M., Edgar, J. M., Lehning, M., Strauß, J., Fleischer, N., Kungl, T., Wieghofer, P., Berghoff, S. A., Reinert, T., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01366-9 · Cited by 101
Cell Type- and Sex-Dependent Transcriptome Profiles of Rat Anterior Pituitary Cells
Fletcher, P. A., Smiljanić, K., Prévide, R. M., Iben, J., Li, T., Rokic, M. B., Sherman, A., Coon, S. L., & Stojilković, S. S. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00623 · Cited by 101
Jevitt, A. M., Chatterjee, D., Xie, G., Wang, X., Otwell, T., Huang, Y., & Deng, W. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000538 · Cited by 101
CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T Cells
Kumar, S., Zeng, Z., Bagati, A., Tay, R. E., Sanz, L. A., Hartono, S. R., Ito, Y., Abderazzaq, F. O., Hatchi, E., Jiang, P., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1144 · Cited by 106
Yang, C., Tian, C., Hoffman, T. E., Jacobsen, N. K., & Spencer, S. L. (2021) · Nature Communications · doi:10.1038/s41467-021-21549-x · Cited by 101
Planarian stem cells specify fate yet retain potency during the cell cycle
Raz, A. A., Wurtzel, O., & Reddien, P. W. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.03.021 · Cited by 101
Xiong, L., Tian, K., Li, Y., Ning, W., Gao, X., & Zhang, Q. C. (2022) · Nature Communications · doi:10.1038/s41467-022-33758-z · Cited by 106
Yang, J., Xing, X., Luo, L., Zhou, X., Feng, J.-X., Huang, K., Liu, H., Jin, S., Liu, Y.-N., Zhang, S.-H., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.abq2424 · Cited by 101
Distinct roles of TREM2 in central nervous system cancers and peripheral cancers
Zhong, J., Xing, X., Gao, Y., Pei, L., Lu, C., Sun, H., Lai, Y., Du, K., Xiao, F., Yang, Y., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.05.001 · Cited by 100
Isakova, A., Neff, N. F., & Quake, S. R. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2113568118 · Cited by 104
Kim, M. Y., Jayasinghe, R. G., Devenport, J. M., Ritchey, J., Rettig, M. P., O’Neal, J., Staser, K. W., Kennerly, K., Carter, A. J., Gao, F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30860-0 · Cited by 99
Oncofetal reprogramming in tumour development and progression
Sharma, A., Blériot, C., Currenti, J., & Ginhoux, F. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00497-8 · Cited by 104
Deciphering Tumor Ecosystems at Super-Resolution from Spatial Transcriptomics with Tesla
Hu, J., Coleman, K., Zhang, D., Lee, E. B., Kadara, H. N., Wang, L., & Li, M. (2022) · Cell Systems · doi:10.1016/j.cels.2023.03.008 · Cited by 99
A developmental constraint model of cancer cell states and tumor heterogeneity
Patel, A. S., & Yanai, I. (2024) · Cell · doi:10.1016/j.cell.2024.04.032 · Cited by 101
Advances in single-cell RNA sequencing and its applications in cancer research
Zhu, S., Qing, T., Zheng, Y., Li, J., & Shi, L. M. (2017) · Oncotarget · doi:10.18632/oncotarget.17893 · Cited by 98
Levitin, H. M., Yuan, J., Cheng, Y. L., Ruiz, F. J. R., Bush, E. C., Bruce, J. N., Canoll, P., Iavarone, A., Lasorella, A., Blei, D. M., et al. (2019) · Molecular Systems Biology · doi:10.15252/msb.20188557 · Cited by 98
Griffiths, J. I., Wallet, P., Pflieger, L. T., Stenehjem, D. D., Liu, X., Cosgrove, P. A., Leggett, N. A., McQuerry, J. A., Shrestha, G., Rossetti, M. M., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1918937117 · Cited by 100
Liu, J., Wang, J., Xu, J., Xia, H., Wang, Y., Zhang, C., Chen, W., Zhang, H., Liu, Q., Zhu, R., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00329-3 · Cited by 96
Guo, W., Zhang, C., Wang, X., Dou, D., Chen, D., & Li, J. (2021) · JCI Insight · doi:10.1172/jci.insight.152616 · Cited by 101
He, L., Fan, Y., Zhang, Y., Tu, T.-T., Zhang, Q., Yuan, F., & Cheng, C. (2022) · Journal of Pineal Research · doi:10.1111/jpi.12803 · Cited by 98
Spitzer, A., Johnson, K. C., Nomura, M., Garofano, L., Nehar-Belaid, D., Darnell, N. G., Greenwald, A., Bussema, L., Oh, Y. T., Varn, F. S., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02168-4 · Cited by 107
Self-citationAnand, P., Guillaumet-Adkins, A., Dimitrova, V., Yun, H., Drier, Y., Sotudeh, N., Rogers, A. J., Ouseph, M. M., Nair, M. S., Potdar, S. V., et al. (2020) · Blood · doi:10.1182/blood.2019004547 · Cited by 97
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy
Trefny, M. P., Kirchhammer, N., der Maur, P. A., Natoli, M., Schmid, D., Germann, M., Fernandez-Rodriguez, L., Herzig, P., Lötscher, J., Akrami, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35583-w · Cited by 98
Sabatier, M., Birsen, R., Lauture, L., Mouche, S., Angelino, P., Dehairs, J., Goupille, L., Boussaid, I., Heiblig, M., Boët, E., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0411 · Cited by 97
Multiomics and spatial mapping characterizes human CD8 + T cell states in cancer
Naulaerts, S., Datsi, A., Borràs, D., Antoranz, A., Messiaen, J., Vanmeerbeek, I., Sprooten, J., Laureano, R. S., Govaerts, J., Panovska, D., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.add1016 · Cited by 99
Lasorsa, F. M., Rutigliano, M., Milella, M., Ferro, M., Pandolfo, S. D., Crocetto, F., Simone, S., Gesualdo, L., Battaglia, M., Ditonno, P., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216515 · Cited by 97
Pao, W. J., Ooi, C.-H., Birzele, F., Ruefli-Brasse, A. A., Cannarile, M. A., Reis, B., Scharf, S. H., Schubert, D. A., Hatje, K., Pelletier, N., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1320 · Cited by 96
Genome-scale screens identify factors regulating tumor cell responses to natural killer cells
Sheffer, M., Lowry, E., Beelen, N. A., Borah, M., Amara, S. N.-A., Mader, C. C., Roth, J. A., Tsherniak, A., Freeman, S. S., Dashevsky, O., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00889-w · Cited by 96
Metadata
- Authors
- Tirosh, I., Izar, B., Prakadan, S. M., Wadsworth, M. H., Treacy, D., Trombetta, J. J., Rotem, A., Rodman, C., Lian, C., Murphy, G., Fallahi-Sichani, M., Dutton-Regester, K., Lin, J.-R., Cohen, O., Shah, P., Lu, D., Genshaft, A. S., Hughes, T. K., Ziegler, C. G. K., Kazer, S. W., Gaillard, A., Kolb, K. E., Villani, A.-C., Johannessen, C. M., Andreev, A. Y., Van Allen, E. M., Bertagnolli, M., Sorger, P. K., Sullivan, R. J., Flaherty, K. T., Frederick, D. T., Jané-Valbuena, J., Yoon, C. H., Rozenblatt-Rosen, O., Shalek, A. K., Regev, A., & Garraway, L. A.
- Affiliations
- Broad Institute (US)
- Brigham and Women's Hospital (US)
- Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA.
- Program in Therapeutic Sciences, Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
- Harvard University (US)
- Massachusetts General Hospital (US)
- Corresponding author
- Tirosh, Itay
- Izar, Benjamin
- Yoon, Charles H.
- Shalek, Alex K.
- Regev, Aviv
- Garraway, Levi A.
- ORCID
- Tirosh, Itay
- Izar, Benjamin
- Prakadan, Sanjay M.
- Wadsworth, Marc H.
- Rotem, Asaf
- Rodman, Christopher
- Lian, Christine
- Lin, Jia-Ren
- Cohen, Ofir
- Shah, Parin
- Genshaft, Alex S.
- Hughes, Travis K.
- Ziegler, Carly G. K.
- Kazer, Samuel W.
- Kolb, Kellie E.
- Villani, Alexandra-Chloé
- Johannessen, Cory M.
- Bertagnolli, Monica
- Sorger, Peter K.
- Sullivan, Ryan J.
- Flaherty, Keith T.
- Frederick, Dennie T.
- Yoon, Charles H.
- Shalek, Alex K.
- Regev, Aviv
- Garraway, Levi A.
- Venue
- Science
- Published
- 2016-04-08
- Volume
- 352
- Issue
- 6282
- Pages
- 189-196
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC4944528
- OpenAlex
- W2332292689
- Cited by
- 4,944
- References
- 70
- Citations by year
- 2026: 546 · 2025: 629 · 2024: 633 · 2023: 606 · 2022: 582 · 2021: 608 · 2020: 486 · 2019: 336 · 2018: 265 · 2017: 195 · 2016: 41
- FWCI
- 145.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- PMC
- Funders
- National Cancer Institute (NCI) (P01CA163222, R35CA197737)
- Dr. Miriam and Sheldon Adelson Medical Research Foundation
- Melanoma Research Alliance
- Ludwig Center at Harvard Medical School
- Howard Hughes Medicine Institute
- Klarman Cell Observatory
- STARR Cancer Consortium
- Broad Institute
- Searle Scholars Program
- Beckman Young Investigator Program
- Dana-Farber Cancer Institute
- Human Frontier Science Program
- Integrative Cancer Biology Program (U54CA112962)
- NCI (1U24CA180922, P30-CA14051, K99CA194163)
- NIH (DP2 OD020839, P50GM107618)
- Ludwig Center at Harvard
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Keywords
- metastatic melanoma, tumor microenvironment, tumor heterogeneity, MITF, AXL kinase, drug resistance, tumor-infiltrating T cells, T cell exhaustion, clonal expansion, tumor stroma, endothelial cells, cell-cell interactions, immunotherapy
- MeSH terms
- Base Sequence, Cell Communication, Cell Cycle, Humans, Immunotherapy, Lymphocyte Activation, Melanoma, Neoplasm Metastasis, RNA, Skin Neoplasms, T-Lymphocytes, Stromal Cells, Sequence Analysis, RNA, Drug Resistance, Neoplasm, Genomics, Endothelial Cells, Microphthalmia-Associated Transcription Factor, Single-Cell Analysis, Tumor Microenvironment, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
